半岛bd体育手机客户端 说明
一般描述
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Leflunomide belongs to the new class of immunomodulating drugs with inflammatory and immunomodulating properties. It has been investigated for application in transplantation procedures. It is also an anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA). Its mode of action involves the inhibition of T-cell proliferation after converting to its active metabolite i.e. A771726 in humans.
应用
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Leflunomide may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using chromatography techniques.
分析说明
These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance withISO 17034andISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAA1634 in the slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
经验(实验)分子式 | C12H9F3N2O2 |
分子量 | 270.21 |
MDL编号 | MFCD00867593 |
PubChem化学物质编号 | 329823355 |
NACRES | NA.24 |
半岛bd体育手机客户端 性质
质量水平 | 300 |
等级 | certified reference material pharmaceutical secondary standard |
CofA | current certificate can be downloaded |
technique(s) | HPLC: suitable gas chromatography (GC): suitable |
application(s) | pharmaceutical (small molecule) |
格式 | neat |
药典可追溯性 | traceable to PhEur Y0000654 traceable to USP 1356960 |
储存温度 | 2-8℃ |
SMILES string | Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F |
InChI | 1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18) |
InChI key | VHOGYURTWQBHIL-UHFFFAOYSA-N |
Gene Information | human ... DHODH(1723) |
安全信息
象形图 | |
警示用语: | Danger |
危险声明 | H301 - H315 - H319 - H335 |
预防措施声明 | P261 - P264 - P270 - P301 + P310 - P302 + P352 - P305 + P351 + P338 |
危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
靶器官 | Respiratory system |
储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
WGK | WGK 1 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
SUPELCO